University of Chicago-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Chicago - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013179
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master’s and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biology, biophysical sciences, business, cancer biology, chemistry, classics, comparative human development, statistics, religious studies, sociology, comparative literature, computational neuroscience and computer science, among others. It offers medical studies through Pritzker School of medicine. The university operates institutes and research centers in France, the US, China, India, Hong Kong and Bangladesh. UOC is headquartered in Chicago, Illinois, the US.

University of Chicago – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Chicago, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Chicago, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Chicago, Medical Devices Deals, 2011 to YTD 2017 10
University of Chicago, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Chicago, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 12
AbbVie Enters into Research Agreement with University of Chicago 13
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 14
Evelo Therapeutics Partners with University of Chicago 15
Celgene Partners with Recombinant Antibody Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Merger 18
Advocate Health Care to Merge with NorthShore University Health System 18
Licensing Agreements 19
Evelo Biosciences Enters into Licensing Agreement with University of Chicago 19
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 20
University of Chicago – Key Competitors 21
University of Chicago – Key Employees 22
University of Chicago – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Strategy And Business Planning 25
Oct 27, 2016: Scientist Builds Drug Development Company Out of Research Lab 25
Government and Public Interest 27
Nov 17, 2017: Researchers receive $500,000 grant to study the microbiome of death 27
Nov 15, 2017: Wider sampling of tumor tissues may guide drug choice, improve outcomes 28
Nov 08, 2017: Novel approach could limit common complications of immunotherapy 30
Oct 19, 2017: Merck Foundation Launches Five-Year Initiative to Improve Diabetes Care for Vulnerable and Underserved U.S. Communities 31
Oct 18, 2017: Globus expands data services to accelerate secure cancer research 32
Sep 27, 2017: UChicago’s Ci3 receives NIH grant to increase access to HIV prevention medication in community pharmacies 33
Aug 24, 2017: Novel RNA Discoveries Could Improve Stem Cell Research 34
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 36
Sep 22, 2016: UChicago among Institutions Nationwide to Get $157 Million in NIH Awards 38
Jun 08, 2016: Antibodies triggered by avian influenza virus vaccine illuminate a new path toward a universal flu vaccine 40
Mar 21, 2016: Janssen Therapeutics Announces Funding for Organizations Focused on Improving Care and Treatment for Vulnerable Populations Living with HIV 41
Other Significant Developments 42
Jul 08, 2016: Rush Participating in NIH Precision Medicine Study of 1 Million 42
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
University of Chicago, Pharmaceuticals & Healthcare, Key Facts 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Chicago, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Chicago, Deals By Therapy Area, 2011 to YTD 2017 9
University of Chicago, Medical Devices Deals, 2011 to YTD 2017 10
University of Chicago, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 12
AbbVie Enters into Research Agreement with University of Chicago 13
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 14
Evelo Therapeutics Partners with University of Chicago 15
Celgene Partners with Recombinant Antibody Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Advocate Health Care to Merge with NorthShore University Health System 18
Evelo Biosciences Enters into Licensing Agreement with University of Chicago 19
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 20
University of Chicago, Key Competitors 21
University of Chicago, Key Employees 22
University of Chicago, Subsidiaries 23

★海外企業調査レポート[University of Chicago-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company’s manufactures products for analgesic and antipyretic, antibiotic, anticoagulant, disinfectant and antiseptic, iron supplement, neurology, …
  • Hilton Grand Vacations Inc (HGV):企業の財務・戦略的SWOT分析
    Hilton Grand Vacations Inc (HGV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • MediWound Ltd (MDWD):企業の財務・戦略的SWOT分析
    MediWound Ltd (MDWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Datatec Ltd (DTC):企業の財務・戦略的SWOT分析
    Datatec Ltd (DTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Australian Vanadium Ltd (YRR):企業の財務・戦略的SWOT分析
    Summary Australian Vanadium Ltd (AVL), formerly Yellow Rock Resources Ltd, is a mining company that explores and develops titanium, vanadium, copper, gold, and uranium metals. The company’s projects include Gabanintha Gold Copper Project, The Australian Vanadium Project, Coates Vanadium Project, Now …
  • Matrix Composites & Engineering Ltd (MCE):企業の財務・戦略的SWOT分析
    Summary Matrix Composites & Engineering Ltd (Matrix) is a manufacturer and supplier of engineered products and services. The company manufactures and distributes engineered products for developing and utilizing advanced composite and polymer materials technologies. Its products include well construc …
  • ITT Inc.:企業のM&A・事業提携・投資動向
    ITT Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITT Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Petra Diamonds Ltd:企業の戦略・SWOT・財務情報
    Petra Diamonds Ltd - Strategy, SWOT and Corporate Finance Report Summary Petra Diamonds Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EDF Energy Holdings Ltd:発電所・企業SWOT分析
    EDF Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • PetroVietnam Fertilizer and Chemicals Corp (DPM):企業の財務・戦略的SWOT分析
    Summary PetroVietnam Fertilizer and Chemicals Corp (PVFCC), formerly Petrovietnam Fertilizer and Chemicals Company, a subsidiary of Vietnam National Oil and Gas Group, is a chemical company that produces and trades specialty chemicals and fertilizers. The company’s products include prilled Urea, NPK …
  • Taylor Communications Inc:企業の戦略的SWOT分析
    Taylor Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • LivaNova PLC (LIVN):医療機器:M&Aディール及び事業提携情報
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depressio …
  • Solargiga Energy Holdings Ltd (757):電力:M&Aディール及び事業提携情報
    Summary Solargiga Energy Holdings Ltd (Solargiga Energy), a subsidiary of Wafer Works Corp is a renewable energy equipment manufacturer that develops and markets monocrystalline silicon products. The company manufactures monocrystalline silicon solar ingots and wafers, solar cells and photovoltaic m …
  • Fresenius SE & Co KGaA (FRE):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • bioMerieux SA (BIM):企業の財務・戦略的SWOT分析
    bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Surge Global Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Surge Global Energy Inc (Surge Global) is an independent oil and gas exploration, production and trading company. The company acquires, finance and develops oil and gas properties. Its energy and metal commodities comprise natural gas, crude oil, coal, electricity, refined petroleum products …
  • Reliance Industries Limited:企業の戦略・SWOT・財務分析
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Old Mutual Plc:戦略・SWOT・企業財務分析
    Old Mutual Plc - Strategy, SWOT and Corporate Finance Report Summary Old Mutual Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆